Innovative Research's Pooled Normal Human Serum was recently used in the following study:
...for two hours in the presence of 33% normal human serum (Innovative Research, Novi, MI) as a source of complement. The proportion of lysed CD19...
Interactions between ibrutinib and anti-CD20 antibodies; competing effects on the outcome of combination therapy
M Skarzynski, CU Niemann, YS Lee, S Martyr, I Maric - Clinical Cancer Research, 2015...for two hours in the presence of 33% normal human serum (Innovative Research, Novi, MI) as a source of complement. The proportion of lysed CD19...
